Immunization, HepB3 in Venezuela, Bolivarian Republic of
Venezuela, Bolivarian Republic of: Immunization, HepB3 was 62.0% in 2024. ▬ Flat
Immunization, HepB3 in Venezuela, Bolivarian Republic of, 2000–2024
Source: World Health Organization (WHO). Measured in % of one-year-old children.
Analysis
Venezuela, Bolivarian Republic of recorded 62.0% for immunization, hepb3 in 2024.
The figure is up 14.8% on the previous year and down 20.5% over ten years.
Over the whole period, immunization, hepb3 in Venezuela, Bolivarian Republic of peaked at 88.0% in 2005 and was at its lowest, 5.0%, in 2000.
That places Venezuela, Bolivarian Republic of 176th out of 188 countries with data for 2024, putting it in the bottom quarter.
Immunization, HepB3 in Venezuela, Bolivarian Republic of, year by year
| Year | % of one-year-old children | Change |
|---|---|---|
| 2000 | 5.0% | — |
| 2001 | 53.0% | +960.0% |
| 2002 | 60.0% | +13.2% |
| 2003 | 72.0% | +20.0% |
| 2004 | 82.0% | +13.9% |
| 2005 | 88.0% | +7.3% |
| 2006 | 71.0% | -19.3% |
| 2007 | 62.0% | -12.7% |
| 2008 | 53.0% | -14.5% |
| 2009 | 84.0% | +58.5% |
| 2010 | 78.0% | -7.1% |
| 2011 | 78.0% | +0.0% |
| 2012 | 81.0% | +3.8% |
| 2013 | 82.0% | +1.2% |
| 2014 | 78.0% | -4.9% |
| 2015 | 87.0% | +11.5% |
| 2016 | 84.0% | -3.4% |
| 2017 | 66.0% | -21.4% |
| 2018 | 60.0% | -9.1% |
| 2019 | 64.0% | +6.7% |
| 2020 | 54.0% | -15.6% |
| 2021 | 56.0% | +3.7% |
| 2022 | 43.0% | -23.2% |
| 2023 | 54.0% | +25.6% |
| 2024 | 62.0% | +14.8% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 63.0% | 5.0% | 88.0% | 10 |
| 2010s | 75.8% | 60.0% | 87.0% | 10 |
| 2020s | 53.8% | 43.0% | 62.0% | 5 |
Countries ranked near Venezuela, Bolivarian Republic of
More health data for Venezuela, Bolivarian Republic of
- Un projection of annual infant deaths, annual growth rate -1.88 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.44 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,244 deaths per 1,000 people (2090)
- Number of infants who die before age 1 888 deaths (2100)
- Population ages 40-44, male, annual growth rate -0.5341 % change on previous year (2025)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, male, per capita 0.0305 units per person (2025)
- Population ages 45-49, female, annual growth rate 0.7083 % change on previous year (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, female, per capita 0.0318 units per person (2025)
Frequently asked questions
- What is immunization, hepb3 in Venezuela, Bolivarian Republic of?
- Immunization, hepb3 in Venezuela, Bolivarian Republic of was 62.0% in 2024, according to World Health Organization (WHO).
- What is the highest immunization, hepb3 recorded in Venezuela, Bolivarian Republic of?
- The highest recorded value was 88.0% in 2005.
- What is the lowest immunization, hepb3 recorded in Venezuela, Bolivarian Republic of?
- The lowest recorded value was 5.0% in 2000.
- How does Venezuela, Bolivarian Republic of rank for immunization, hepb3?
- Venezuela, Bolivarian Republic of ranks 176th out of 188 countries with data for 2024.
- Is immunization, hepb3 rising or falling in Venezuela, Bolivarian Republic of?
- Over the last ten years it is down 20.5%. The long-run trend across the full record is flat.
- Where does this Venezuela, Bolivarian Republic of data come from?
- The figures come from World Health Organization (WHO), published as part of Immunization, HepB3 (% of one-year-old children). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.